The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.
Sylvia
S
Bellucci
Bruno
B
Cassinat
Nadine
N
Bonnin
Christophe
C
Marzac
Isabelle
I
Crassard
D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D020767:Intracranial Thrombosis / Q000201:enzymology / Q000235:genetics*; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000201:enzymology / Q000235:genetics; D012307:Risk Factors; D020246:Venous Thrombosis / Q000201:enzymology / Q000235:genetics*
C507924:JAK2 protein, human; D053614:Janus Kinase 2